HomeTag#verseaophthalmics - Verséa

https://i0.wp.com/www.versea.com/wp-content/uploads/2023/01/ezgif.com-gif-maker.jpg?resize=1280%2C640&ssl=1

Verséa Ophthalmics invites you to attend the Hawaiian Eye 2023 – Disruptive Innovations Symposium on January 16th from 1pm – 2:30pm HST where Dr. Rob Sambursky, our President, will be presenting the latest Eye Care innovations: Novel, Tear-based Point-of-care (POC) diagnostic platform with 2 quantitative tests, Complementary regenerative therapeutics. These innovative solutions will help you...

https://i0.wp.com/www.versea.com/wp-content/uploads/2022/12/Eye-Care.jpg?resize=1280%2C600&ssl=1

Verséa Ophthalmics is a proud sponsor of this year’s 2022 CEDARS/ASPENS Annual Meeting, taking place today and tomorrow at JW Marriott Camelback, Scottsdale (AZ). CEDARS/ASPENS is a not-for-profit society whose mission is to expand the knowledge of ophthalmic surgery and foster excellence in patient care through clinical experience, peer-to-peer exchange, and practice education. Their mission...

https://i0.wp.com/www.versea.com/wp-content/uploads/2022/11/thumb.jpg?resize=1280%2C640&ssl=1

As part of the corporate exhibit hall interview series at the Eyes On 2023, Verséa Ophthalmics President, Rob Sambursky, MD, was interviewed by Brittany J. McMurren, OD. During the interview, titled “A Deep Dive into New Testing & Therapeutic Innovations”  Rob Sambursky, MD presented new testing and therapeutic innovations that Verséa Ophthalmics is bringing to...